Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

A Multifaced Approach on Psoriasis Pathogenesis

Version 1 : Received: 22 March 2024 / Approved: 24 March 2024 / Online: 25 March 2024 (13:12:28 CET)

How to cite: Dascǎlu, R.C.; Bǎrbulescu, A.L.; Stoica, L.E.; Dinescu, Ş.C.; Bițǎ, C.E.; Popoviciu, H.V.; Ionescu, R.A.; Vreju, F.A. A Multifaced Approach on Psoriasis Pathogenesis. Preprints 2024, 2024031422. https://doi.org/10.20944/preprints202403.1422.v1 Dascǎlu, R.C.; Bǎrbulescu, A.L.; Stoica, L.E.; Dinescu, Ş.C.; Bițǎ, C.E.; Popoviciu, H.V.; Ionescu, R.A.; Vreju, F.A. A Multifaced Approach on Psoriasis Pathogenesis. Preprints 2024, 2024031422. https://doi.org/10.20944/preprints202403.1422.v1

Abstract

Psoriasis is a chronic recurrent inflammatory autoimmune pathology, with a major genetic component and several interferences of immunological cells and their cytokines. The complex orchestration of psoriasis pathogenesis is related to the synergic effect of immune cells, polygenic alterations, the presence of autoantigens and several external factors. The major act of IL-23/IL-17 axis, strongly influencing the inflammatory pattern established during the disease activity, is visible as a continuous perpetuation of the pro-inflammatory response and keratinocyte activation and proliferation leading to the development of psoriatic lesions. Genome wide association studies (GWAS) along offered a better view of psoriasis pathogenic pathways, with approximately one third of psoriasis genetic impact on psoriasis development is associated to MHC region, with genetic loci located on chromosome 6. The most eloquent genetic factor of psoriasis, PSORS1, was identified in the MHC I site. Between the several factors involved in its complex etiology, dysbiosis, due to genetic or external stimulus, exhibiting less variety and the involvement of pathogenic bacteria, cand induce a burst of proinflammatory consequences, both cutaneous and gut microbiome being involved in psoriasis pathogenic process. A complex understanding of the major pathways that interplay in order to initiate and perpetuate psoriatic diseases and its associated comorbidities can help the current clinical practice by properly evaluating completely and individualized each patient and establish the proper therapeutic management.

Keywords

psoriasis; microbiome; genetics; cytokines; signaling pathways

Subject

Medicine and Pharmacology, Medicine and Pharmacology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.